Accessible Requires Authentication Published by De Gruyter September 7, 2020

Minimum retesting intervals in practice: 10 years experience

Tim Lang

Abstract

Background

Minimum retesting intervals (MRI) are a popular demand management solution for the identification and reduction of over-utilized tests. In 2011 Association of Clinical Biochemistry and Laboratory Medicines (ACB) published evidence-based recommendations for the use of MRI.

Aim

The aim of the paper was to review the use of MRI over the period since the introduction of these recommendations in 2011 to 2020 and compare it to previous published data between 2000-2010.

Methods

A multi-source literature search was performed to identify studies that reported the use of a MRI in the management or identification of inappropriate testing between the years prior to (2000–2010) and after implementation (2011–2020) of these recommendations.

Results

31 studies were identified which met the acceptance criteria (2000–2010 n=4, 2011–2020 n=27). Between 2000 and 2010 4.6% of tests (203,104/4,425,311) were identified as failing a defined MRI which rose to 11.8% of tests (2,691,591/22,777,288) in the 2011–2020 period. For those studies between 2011 and 2020 reporting predicted savings (n=20), 14.3% of tests (1,079,972/750,580) were cancelled, representing a total saving of 2.9 M Euros or 2.77 Euro/test. The most popular rejected test was Haemoglobin A1c which accounted for nearly a quarter of the total number of rejected tests. 13 out 27 studies used the ACB recommendations.

Conclusions

MRI are now an established, safe and sustainable demand management tool for the identification and management of inappropriate testing. Evidence based consensus recommendations have supported the adoption of this demand management tool into practice across multiple healthcare settings globally and harmonizing laboratory practice.


Corresponding author: Dr. Tim Lang, Consultant Clinical Scientist, Department of Clinical Biochemistry, University Hospital of North Durham, North Road, Durham, County Durham, DH1 5TW, UK, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

References

1. Greaves, R, Bernardini, S, Ferrari, M, Fortina, P, Gouget, B, Gruson, D, et al. Key questions about the future of laboratory medicine in the next decade of the 21st century: a report from the IFCC-Emerging Technologies Division. Clin Chim Acta 2019;495:570–89. Search in Google Scholar

2. Mrazek, C, Simundic, A-M, Salinas, M, von Meyer, A, Cornes, M, Bauca, JM, et al. Inappropriate use of laboratory tests: how availability triggers demand – Examples across Europe. Clin Chim Acta 2020;505:100–7. Search in Google Scholar

3. Lord Carter of Coles. Report of the second phase of the independent review of NHS pathology services; 2006. https://webarchive.nationalarchives.gov.uk/20130124044941/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_091984.pdf [Accessed 20 April 2020]. Search in Google Scholar

4. Plebani, M, Zaninotto, M, Faggian, D. Utilization management: a European perspective. Clin Chim Acta 2014;427:137–41. Search in Google Scholar

5. Encouraging quality pathology ordering in Australia’s public hospitals – final report; 2012. www.ncopp.org.au [Accessed 20 April 2020]. Search in Google Scholar

6. Zhi, M, Ding, EL, Theisen-Toupal, J, Whelan, J, Arnaout, R. The landscape of inappropriate laboratory testing: a 15 year meta-analysis. PLoS ONE 2013;8:e78962. Search in Google Scholar

7. Driskell, OJ, Holland, D, Hanna, FW, Jones, PW, Pemberton, RJ, Tran, M, Fryer, AA. Inappropriate requesting of glycated haemoglobin (HbA1c) is widespread: assessment of prevalence, impact of National guidance, and practice-to-practice variability. Clin Chem 2012;58:906–15. Search in Google Scholar

8. Fryer, AA, Smellie, WSA. Managing demand for laboratory tests: a laboratory toolkit. J Clin Pathol 2012;66:62–72. Search in Google Scholar

9. Plebani, M. Harmonization of clinical laboratory information – current and future strategies. EJIFCC 2016;27:15–22. Search in Google Scholar

10. Ceriotti, F. Harmonization initiatives in Europe. EJIFCC 2016;27:23–9. Search in Google Scholar

11. Lippi, G, Banfi, G, Church, S, Cornes, M, De Carli, G, Grankvist, K, et al. Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med 2015;53:357–70. Search in Google Scholar

12. Malhotra, A, Maughan, D, Ansell, J, Lehman, R, Henderson, A, Gray, M, et al. Choosing wisely in the UK: the Academy of Medical Royal Colleges’ initiative to reduce harm of too much medicine. BMJ 2015;350:h2308. Search in Google Scholar

13. Plebani, M, Laposata, M, Lundberg, GD. The brain-to-brain loop concept for laboratory testing 40 years after its introduction. Am J Clin Path 2011;136:829–33. Search in Google Scholar

14. Horvath, AR. From evidence to best practice in laboratory medicine. Clin Biochem Rev 2013;34:47–60. Search in Google Scholar

15. Smit, I, Zemlin, AE, Eramus, RT. Demand management: an audit of chemical pathology test rejections by an electronic gate-keeping system at an academic hospital in Cape Town. Ann Clin Biochem 2015;52:481–7. Search in Google Scholar

16. Eaton, KP, Levy, K, Soong, C, Pahwa, AK, Petrilli, C, Ziemba, JB, et al. Evidence-based guidelines to eliminate repetitive laboratory testing. JAMA Int Med 2017;177:1833–9. Search in Google Scholar

17. Lang, T. Laboratory demand management of repetitive testing – time for harmonisation and an evidenced based approach. Clin Chem Lab Med 2013;51:1139–40. Search in Google Scholar

18. Lang, TF. National Minimum Re-testing Intervals Project: a final report detailing consensus recommendations for minimum re-testing intervals for use in Clinical Biochemistry. London: Association for Clinical Biochemistry; 2013, p. 2012. Search in Google Scholar

19. Van Walraven, C, Raymond, M. Population-based study of repeat laboratory testing. Clin Chem 2003;49:1997–2005. Search in Google Scholar

20. Kwok, J, Jones, B. Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory. J Clin Path 2005;58:457–62. Search in Google Scholar

21. May, TA, Clancy, M, Critchfield, J, Ebeling, F, Enriquez, A, Gallagher, C, Genevro, J, Kloo, J, Lewis, P, Smith, R, Ng, VL. Reducing unnecessary inpatient laboratory testing in a teaching hospital. Am J Clin Path 2006;126:200–6. Search in Google Scholar

22. Akan, P, Cimrin, D, Ormen, M, Kume, T, Ozkaya, A, Ergor, G, et al. The inappropriate use of HbA1c testing to monitor glycemia: is there evidence in laboratory data?. J Eval Clin Pract 2007;13:21–4. Search in Google Scholar

23. Glaser, EM. Using behavioral science strategies for defining the state-of-the-art. J Appl Behav Sci 1980;16:79–92. Search in Google Scholar

24. Lang, TF, Croal, B National Minimum Re-testing Intervals in Pathology Project: a final report detailing consensus recommendations for minimum retesting intervals for use in pathology. London: Royal College of Pathologists; 2015. p. 1–59. Search in Google Scholar

25. Janssens, PMW, Wasser, G. Managing laboratory test ordering through test frequency filtering. Clin Chem Lab Med 2013;51:1207–15. Search in Google Scholar

26. Luo, RF, Spradley, S, Banaei, N. Alerting physicians during electronic order entry effectively reduces unnecessary repeat PCR testing for clostridium difficile. J Clin Micro 2013;51:3872–4. Search in Google Scholar

27. Bellodi, E, Vagnoni, E, Bonvento, B, Lamma, E. Economic and organizational impact of a clinical decision support system on laboratory test ordering. BMC Med Inform Decis Making 2017;17:179–87. Search in Google Scholar

28. Pelloso, M, Basso, D, Padoan, A, Fogar, P, Plebani, M. Computer-based-limited and personalised education management maximise appropriateness of vitamin D, vitamin B12 and folate restesting. J Clin Path 2015;69:777–83. Search in Google Scholar

29. Lippi, G, Brambilla, M, Bonelli, P, Aloe, R, Balestrino, A, Nardelli, A, Ceda, GP, Fabi, M. Effectiveness of a computerized alert system based on re-testing intervals for limiting the appropriateness of laboratory tests requests. Clin Biochem 2015;48:1174–6. Search in Google Scholar

30. Gothheil, S, Khemani, E, Copley, K, Keeney, M, Chin-Yee, I, Gob, A. Reducing inappropriate ESR testing with computerized clinical decision support. BMJ Open Qual 2016;5:u211376. Search in Google Scholar

31. Hure, A, Palazzi, K, Peel, R, Geraghty, D, Collard, P, De Malmanche, T, et al. Identifying low value pathology test ordering in hospitalised patients: a retrospective cohort study across two hospitals. Pathology 2019;51:621–7. Search in Google Scholar

32. Pageler, NM, Franzon, D, Longhurst, CA, Wood, M, Shin, AY, Adams, ES, et al. Embedding time-limited laboratory orders within computerized provider order entry reduces laboratory utilization. Pedatr Crit Care Med 2013;14:413–9. Search in Google Scholar

33. McCoy, RG, Van Houten, HK, Ross, JS, Montoni, VM, Shah, ND. HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001–13: observational population based study. BMJ 2015;351:h6138. Search in Google Scholar

34. Mahomed, OH, Lekalakala, R, Asmail, S, Cassim, N. Implications of the introduction of laboratory demand management at primary care clinics in South Africa on laboratory expenditure. Afr J Lab Med 2016;5:339. Search in Google Scholar

35. Hueth, KD, Jackson, BR, Schmidt, RL. An audit of order patterns with recommendations and potential cost savings. Am J Clin Path 2018;150:27–33. Search in Google Scholar

36. Morgan, EK, Naugler, C. Inappropriate repeats of six common tests in a Canadian city: a population cohort study within a laboratory informatics framework. Am J Clin Pathol 2015;144:704–12. Search in Google Scholar

37. Konger, Rl, Ndekwe, P, Jone, G, Schmidt, RP, Trey, M, Baty, EJ, Wilhite, D, Munshi, IA, Sutter, BM, Rao, M, Bashir, Cm. Reduction in unnecessary clinical laboratory testing through utilization management at a US Government Veterans Affairs Hospital. Am J Clin Path 2016;145:355–64. Search in Google Scholar

38. Iliadi, V, Kastanioti, C, Maropoulos, G, Niakas, D. Inappropriately repeated lipid tests in a tertiary hospital in Greece: the magnitude and cost of the phenomenon. Hippokratia 2012;16:261–6. Search in Google Scholar

39. Procop, GW, Yerian, LM, Wyllie, R, Harrison, AM, Kottke-Marchant, K. Duplicate laboratory test reduction using a clinical decision support tool. Am J Clin Pathol 2014;141:718–23. Search in Google Scholar

40. Waldron, JL, Ford, C, Dobie, D, Danks, G, Humphrey, R, Rolli, A, Gama, R. An automated minimum retest interval rejection rule reduces repeat CRP workload and expenditure, and influences clinician-requesting behaviour. J Clin Pathol 2014;67:731–3. Search in Google Scholar

41. Demir, S, Zorbozan, N, Basak, E. Unnecessary repeated total cholesterol tests in biochemistry laboratory. Biochem Med 2016;26:77–81. Search in Google Scholar

42. Galovic, R, Fucek, M, Rogic, D. Minimum retesting intervals – application through electronic order forms on common laboratory tests. Signa Vitae 2016;11:77–9. Search in Google Scholar

43. Hawkins, R. Audit of inpatient gamma glutamyl transferase repeat testing. Clin Chem Lab Med 2017;55:S817. Search in Google Scholar

44. Lanzoni, M, Fornili, M, Felicetta, I, Maiavacca, R, Biganzoli, E, Castali, S. Three-year analysis of repeated laboratory tests for the markers total cholesterol, ferritin, vitamin D, vitamin B12, and folate, in a large research and teaching hospital in Italy. J Eval Clin Pract 2017;23:654–61. Search in Google Scholar

45. Chami, N, Simons, JE, Don-Wauchope, AC. Rates of inappropriate laboratory test utilization in Ontario. Clin Biochem 2017;50:822–7. Search in Google Scholar

46. Pema, AK, Kiabilua, O, Pillay, TS. Demand management by electronic gatekeeping of test requests does not influence requesting behaviour or save costs dramatically. Ann Clin Biochem 2018;55:244–53. Search in Google Scholar

47. Morris, TF, Ellison, TL, Mutabagani, M, Althawadi, SI, Heppenheimer, M. Demand management and optimization of clinical laboratory services in a tertiary referral center in Saudi Arabia. Ann Saudi Med 2018;38:299–304. Search in Google Scholar

48. Zorbozan, N, Akarken, I. Unnecessary repeated total PSA tests and evaluation with minimum retest interval and reference change value. J Clin Chem Lab Med 2019;2:119. Search in Google Scholar

49. Lapić, I, Rogić, D, Fuček, M, Galović, R. Effectiveness of minimum retesting intervals in managing repetitive laboratory testing: experience from a Croatian university hospital. Biochem Med (Zagreb) 2019;29:030705. Search in Google Scholar

50. Ko, SQ, Quah, P, Lahiri, M. The cost of repetitive laboratory testing for chronic disease. Int Med J 2019;49:1168–70. Search in Google Scholar

51. Kilincarslan, MG, Sahin, Em, Korkmazer, B. Prevalence and associated factors of inappropriate repeat testing. Postgrad Med J 2019;95:595–600. Search in Google Scholar

52. Vrijsen, BEL, Naaktgeboren, CA, Vos, LM, van Solinge, WW, Kaasjager, HAH, ten Berg, MJ. Inappropriate laboratory testing in internal medicine patients: Prevalence, causes and interventions. Ann Med Surg 2020;51:48–53. Search in Google Scholar

53. Mrazek, C, Stechemesser, L, Haschke-Becher, E, Holzl, B, Paulweber, B, Keppel, MH, Simundic, A-M, Oberkofler, H, Felder, TK, Cadamuro, J. Reducing the probability of falsely elevated HbA1c results in diabetic patients by applying automated and educative HbA1c re-testing intervals. Clin Biochem 2020, in press. Search in Google Scholar

54. Salinas, M, Lopez-Garrigos, M, Flores, E, Blasco, A, Leiva-Salinas, C. Less is more: two automated interventions to increase vitamin B12 measurement when long-term proton pump inhibitor and decrease redundant testing. Clin Chim Acta 2020;506:176–9. Search in Google Scholar

55. Salinas, M, Lopez-Garrigos, M, Uris, J. Differences in laboratory requesting patterns in emergency departments in Spain. Ann Clin Biochem 2013;50:353–9. Search in Google Scholar

56. Salinas, M, Lopez-Garrigos, M, Flores, E, Blasco, A, Leiva-Salinas, C. Temporal and regional variability in the request of vitamin D from general practitioners in Spain. Clin Chem Lab Med 2017;55:1754–60. Search in Google Scholar

57. Salinas, M, Lopez-Garrigos, M, Flores, E, Blasco, A, Leiva-Salinas, C. Urinary albumin: a risk marker under-requested in primary care in Spain. Ann Clin Biochem 2018;55:281–6. Search in Google Scholar

58. Hutton, HD, Drummond, HS, Fryer, AA. The rise and fall of C-reactive protein: managing demand within clinical biochemistry. Ann Clin Biochem 2009;46:155–8. Search in Google Scholar

59. Brady, H, Piggott, L, Dunne, S, O’Connell, NH, Dunne, CP. Clustered interventions to reduce inappropriate duplicate laboratory testing in an Irish tertiary hospital. Clin Biochem 2018;52:26–32. Search in Google Scholar

Received: 2020-05-06
Accepted: 2020-06-22
Published Online: 2020-09-07
Published in Print: 2021-01-26

© 2020 Walter de Gruyter GmbH, Berlin/Boston